Uzi Hadad

1.0k total citations
39 papers, 767 citations indexed

About

Uzi Hadad is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Uzi Hadad has authored 39 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Immunology and 8 papers in Oncology. Recurrent topics in Uzi Hadad's work include Immune Cell Function and Interaction (17 papers), RNA Interference and Gene Delivery (5 papers) and T-cell and B-cell Immunology (5 papers). Uzi Hadad is often cited by papers focused on Immune Cell Function and Interaction (17 papers), RNA Interference and Gene Delivery (5 papers) and T-cell and B-cell Immunology (5 papers). Uzi Hadad collaborates with scholars based in Israel, United States and United Kingdom. Uzi Hadad's co-authors include Angel Porgador, Benyamin Rosental, Michael Brusilovsky, Rami Yossef, Avishay Edri, Kerry S. Campbell, Michael Y. Appel, Alex Braiman, Guillaume Le Saux and Mark Schvartzman and has published in prestigious journals such as Advanced Materials, The Journal of Immunology and PLoS ONE.

In The Last Decade

Uzi Hadad

37 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uzi Hadad Israel	17	443	226	186	66	54	39	767
Trinidad Hernández‐Caselles Spain	19	525 1.2×	346 1.5×	159 0.9×	34 0.5×	99 1.8×	34	1.1k
Brandon Lam United States	13	325 0.7×	270 1.2×	149 0.8×	63 1.0×	70 1.3×	34	766
Christine Häfner Austria	23	228 0.5×	326 1.4×	205 1.1×	61 0.9×	42 0.8×	65	1.2k
Nahum Puebla‐Osorio United States	19	366 0.8×	469 2.1×	314 1.7×	61 0.9×	55 1.0×	43	1.0k
Pedro Roda‐Navarro Spain	21	661 1.5×	376 1.7×	265 1.4×	60 0.9×	85 1.6×	45	1.1k
Yutaka Arimura Japan	19	535 1.2×	503 2.2×	158 0.8×	34 0.5×	97 1.8×	34	1.0k
Martin Schlapschy Germany	17	225 0.5×	651 2.9×	178 1.0×	77 1.2×	55 1.0×	31	1.0k
Steven A. Chmura United States	8	353 0.8×	351 1.6×	93 0.5×	60 0.9×	60 1.1×	10	853
Marco Cavallari Switzerland	16	809 1.8×	378 1.7×	202 1.1×	30 0.5×	97 1.8×	26	1.3k
Sherry L. LaPorte United States	9	510 1.2×	363 1.6×	268 1.4×	23 0.3×	45 0.8×	11	1.2k

Countries citing papers authored by Uzi Hadad

Since Specialization

Citations

This map shows the geographic impact of Uzi Hadad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uzi Hadad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uzi Hadad more than expected).

Fields of papers citing papers by Uzi Hadad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uzi Hadad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uzi Hadad. The network helps show where Uzi Hadad may publish in the future.

Co-authorship network of co-authors of Uzi Hadad

This figure shows the co-authorship network connecting the top 25 collaborators of Uzi Hadad. A scholar is included among the top collaborators of Uzi Hadad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uzi Hadad. Uzi Hadad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cohen, Limor, Riki Goldbart, Tamar Traitel, et al.. (2025). Targeted siRNA Delivery Using Cetuximab‐Conjugated Starch for Epidermal Growth Factor Receptor‐Driven Head and Neck Squamous Cell Carcinoma. Small Science. 5(7). 2500073–2500073.

Hadad, Uzi, et al.. (2025). Relative Distribution of DnaA and DNA in Escherichia coli Cells as a Factor of Their Phenotypic Variability. International Journal of Molecular Sciences. 26(2). 464–464. 2 indexed citations

Yegodayev, Ksenia M., Uzi Hadad, Riki Goldbart, et al.. (2024). The Potential of PIP3 in Enhancing Wound Healing. International Journal of Molecular Sciences. 25(3). 1780–1780. 4 indexed citations

Levitas, Aviva, Alex Braiman, Uzi Hadad, et al.. (2023). A Missense Variation in PHACTR2 Associates with Impaired Actin Dynamics, Dilated Cardiomyopathy, and Left Ventricular Non-Compaction in Humans. International Journal of Molecular Sciences. 24(2). 1388–1388. 2 indexed citations

Hadad, Uzi, et al.. (2022). Metaphase Cells Enrichment for Efficient Use in the Dicentric Chromosome Assay. Cell Biochemistry and Biophysics. 80(4). 647–656.

Saux, Guillaume Le, Avishay Edri, Long Li, et al.. (2021). Molecular-scale spatio-chemical control of the activating-inhibitory signal integration in NK cells. Science Advances. 7(24). 16 indexed citations

Hadad, Uzi, Orly Gershoni‐Yahalom, William E. Browne, et al.. (2021). Functional Characterization of Hexacorallia Phagocytic Cells. Frontiers in Immunology. 12. 662803–662803. 21 indexed citations

Hadad, Uzi, et al.. (2021). Distinct features of the Leishmania cap-binding protein LeishIF4E2 revealed by CRISPR-Cas9 mediated hemizygous deletion. PLoS neglected tropical diseases. 15(3). e0008352–e0008352. 7 indexed citations

Ivanković, Tomislav, et al.. (2020). Capillary bacterial migration on non-nutritive solid surfaces. Archives of Industrial Hygiene and Toxicology. 71(3). 251–260. 2 indexed citations

10.

Hadad, Uzi, et al.. (2020). Non‐pigmented ciliary epithelium derived extracellular vesicles uptake mechanism by the trabecular meshwork. The FASEB Journal. 35(2). e21188–e21188. 14 indexed citations

11.

Saux, Guillaume Le, et al.. (2020). Mechanical Regulation of the Cytotoxic Activity of Natural Killer Cells. ACS Biomaterials Science & Engineering. 7(1). 122–132. 25 indexed citations

12.

Saux, Guillaume Le, Ashish Pandey, Avishay Edri, et al.. (2018). Natural killer cells’ immune response requires a minimal nanoscale distribution of activating antigens. Nanoscale. 10(30). 14651–14659. 24 indexed citations

13.

Saux, Guillaume Le, et al.. (2018). Spatial and Chemical Surface Guidance of NK Cell Cytotoxic Activity. ACS Applied Materials & Interfaces. 10(14). 11486–11494. 11 indexed citations

14.

Saux, Guillaume Le, et al.. (2018). Nanoscale Mechanosensing of Natural Killer Cells is Revealed by Antigen‐Functionalized Nanowires. Advanced Materials. 31(4). e1805954–e1805954. 52 indexed citations

15.

Edri, Avishay, Avishai Shemesh, Muhammed Iraqi, et al.. (2018). The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells. Frontiers in Immunology. 9. 1428–1428. 18 indexed citations

16.

Yossef, Rami, Chamutal Gur, Avishai Shemesh, et al.. (2015). Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PLoS ONE. 10(2). e0118936–e0118936. 21 indexed citations

17.

Hadad, Uzi, Olivia M. Martinez, & Sheri M. Krams. (2014). NK cells after transplantation: friend or foe. Immunologic Research. 58(2-3). 259–267. 25 indexed citations

18.

Brusilovsky, Michael, et al.. (2012). PCNA: a novel cancer-associated ligand for the NK cell receptor NKp44 (162.10). The Journal of Immunology. 188(1_Supplement). 162.10–162.10. 1 indexed citations

19.

Kuzmina, Alona, Uzi Hadad, Koh Fujinaga, & Ran Taube. (2012). Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1. Virology. 426(2). 152–161. 2 indexed citations

20.

Rosental, Benyamin, Michael Y. Appel, Rami Yossef, et al.. (2012). The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells. Current Medicinal Chemistry. 19(12). 1780–1791. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact